[Adjuvant treatment of peptic ulcer bleeding].
Schilling
D
D
Medizinische Klinik C, Gastroenterologie, Hepatologie und Diabetologie, Klinikum der Stadt Ludwigshafen gGmbH. Schillid@klilu.de
Hartmann
D
D
Eickhoff
A
A
Jakobs
R
R
Riemann
J F
JF
D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000401:mortality; D004384:Duodenoscopy; D019160:Endosonography; D005773:Gastroscopy; D006489:Hemostatic Techniques; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D017052:Hospital Mortality; D006801:Humans; D010438:Peptic Ulcer Hemorrhage / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000401:mortality; D054328:Proton Pump Inhibitors; D055502:Secondary Prevention; D013004:Somatostatin / Q000627:therapeutic use; D013276:Stomach Ulcer / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000401:mortality
D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors; D013004:Somatostatin